EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Roles of Goserelin in Gynecological Disorders

Xiufeng Huang iD, Nihao Gu iD, Linhua Qian iD, Feng Sun iD, Shizhou Yang iD, Hong Xu iD

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-22

DOI: 10.2147/dddt.s595029 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Xiufeng Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Goserelin, Genital Diseases, Female. Die Arbeit nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Goserelin is a gonadotropin-releasing hormone (GnRH) agonist with a long history of clinical application and well-established efficacy and safety profile. Its mechanism of action centers on sustained GnRH receptor desensitization, leading to pituitary downregulation, ovarian suppression, and reduction of estradiol and progesterone to postmenopausal levels; this forms the basis for its efficacy in hormone-dependent gynecological conditions. Over the past three decades, the use of goserelin has been expanded to an increasing number of indications and clinical scenarios. Approved gynecological indications of goserelin include endometriosis, uterine fibroids, usage as an agent for endometrial thinning, and usage as an agent for ovarian downregulation prior to assisted reproduction. More recent research continues to explore the use of goserelin in gynecological diseases such as adenomyosis and different types of female cancers. Goserelin may also be a useful tool in clinical scenarios where gynecologic management is required as part of multi-disciplinary therapy. This review consolidates the established and emerging roles of goserelin across the broad spectrum of benign and malignant gynecological conditions, underscoring its remarkable clinical versatility and the breadth of evidence that support its continued expansion of utility in contemporary practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoserelinGenital Diseases, FemaleHumansFemaleGonadotropin-Releasing Hormone

Stichwörter der Autor:innen

benign gynecological disordersfemale cancersgonadotropin-releasing hormone agonistgoserelin

Substanzen

GoserelinGonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Department of Gynecology, Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, People's Republic of China.
  • Department of Gynecology, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, People's Republic of China.
  • Department of Gynecology, the International Peace Maternity & Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Department of Gynecology, Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, People's Republic of China.
  • Department of Gynecology, Shanghai Municipal Key Clinical Specialty, Shanghai, People's Republic of China.

ORCID-Profile: Xiufeng Huang, Nihao Gu, Linhua Qian, Feng Sun, Shizhou Yang, Hong Xu

Zitieren

APA

Huang, X., Gu, N., Qian, L., Sun, F., Yang, S., & Xu, H. (2026). Roles of Goserelin in Gynecological Disorders. Drug Design, Development and Therapy, Volume 20, 1-22. https://doi.org/10.2147/dddt.s595029

Vancouver

Huang X, Gu N, Qian L, Sun F, Yang S, Xu H. Roles of Goserelin in Gynecological Disorders. Drug Design, Development and Therapy. 2026;Volume 20:1-22. doi:10.2147/dddt.s595029

BibTeX
@article{Huang2026,
  author = {Huang, Xiufeng and Gu, Nihao and Qian, Linhua and Sun, Feng and Yang, Shizhou and Xu, Hong},
  title = {Roles of Goserelin in Gynecological Disorders},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--22},
  doi = {10.2147/dddt.s595029}
}
Kostenlos starten →